Next Reorg

Quote



HCPs don’t care about indications. Get over it super reps. The Ozempic ship has sailed and it’s not coming back. It’s the natural order of things. What goes up, must come down. Sales, the stock, and soon, the size of the workforce at Novo. All on the decline. Surprised? Then you should be on the LT. I’m sure they’re surprised too. They all have a “best two years ever” hangover.
 






anonymous said:
Bring it on!! This greedy shit show of a company deserves to sink. Novo launched Wegovy and ran out of product within months. It took them 3 YEARS to have Wegovy supply. I wholeheartedly believe they only have enough supply now because no one is prescribing. Lilly has the superior product. Oh wait , we have CV indication. No one cares. If the patient looses weight their CV risks decline. All of their risks for health issues associated with obesity decrease. Oh wait we sample! Again, obviously no one cares. Bring on a package.
Click to expand...
I am a former Lilly rep (Mounjaro, Zepbound) who got caught up in the reorg. If I was a Novo rep selling Ozempic and Weygovy i would hit the 12-18 yeqr olds fatties hard at pediatricians offices'. Zepbound is 18 and over. I would focus on the 2mg dose studies that bridge the gap as far as A1C and weight loss vs Mounjaro.
 




The day of the pharma rep is over. AI, remote reps who work for a fraction of the price, formularies/rebates dictating product section. Get a back up plan. Especially here. One molecule that every one knows about. What is there to sell?
 


anonymous said:
HCPs don’t care about indications. Get over it super reps. The Ozempic ship has sailed and it’s not coming back. It’s the natural order of things. What goes up, must come down. Sales, the stock, and soon, the size of the workforce at Novo. All on the decline. Surprised? Then you should be on the LT. I’m sure they’re surprised too. They all have a “best two years ever” hangover.
Click to expand...
Not Ludovic. He has no hangover; RareD struggled immensely over the past two years. He’s just getting ready for the challenge.
 


anonymous said:
HCPs don’t care about indications. Get over it super reps. The Ozempic ship has sailed and it’s not coming back. It’s the natural order of things. What goes up, must come down. Sales, the stock, and soon, the size of the workforce at Novo. All on the decline. Surprised? Then you should be on the LT. I’m sure they’re surprised too. They all have a “best two years ever” hangover.
Click to expand...
Not Ludovic. He has no hangover; RareD struggled immensely over the past two years. He’s just getting ready for the challenge
 










I don’t think they’ll wait until year end for a reorg. Fired Lars which means they don’t like the strategy. If you don’t like the strategy then the sales footprint must not be right either? And if they don’t like Lars direction what about US direction? Being more than 50% of profits and sales, the US structure isn’t working, and needs to change! Not in 2026. More likely in the fall.
 


anonymous said:
I don’t think they’ll wait until year end for a reorg. Fired Lars which means they don’t like the strategy. If you don’t like the strategy then the sales footprint must not be right either? And if they don’t like Lars direction what about US direction? Being more than 50% of profits and sales, the US structure isn’t working, and needs to change! Not in 2026. More likely in the fall.
Click to expand...
For sure, lots of changes will come, not just under Dave, but for sure also in Development. That screw-up can’t be left unaddressed for much longer.
 


layoffs coming. It doesn’t matter if you are DCS, OCS, EDCS, CV. It’s not based on your current role. Any rep can be placed in any position. Educators are safe as per usual. Be open to looking for a new job. It’s easier to find one when you have one.
 


Anonie said:
The day of the pharma rep is over. AI, remote reps who work for a fraction of the price, formularies/rebates dictating product section. Get a back up plan. Especially here. One molecule that every one knows about. What is there to sell?
Click to expand...
It’s not over….just over pretty soon for 50% of us here. Prepare folks.
 









Write your reply...
Top Bottom
Back
Quote